The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation
Qinchao Hu(Sun Yat-sen University), Bin Cheng(Sun Yat-sen University)
Cited by 22
Related Papers
Metformin as a senostatic drug enhances the anticancer efficacy of CDK4/6 inhibitor in head and neck squamous cell carcinoma
|Cell Death and Disease|2020|71
Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis
|Scientific Reports|2016|69
Overexpression of miR-155 promotes the proliferation and invasion of oral squamous carcinoma cells by regulating BCL6/cyclin D2
|International Journal of Molecular Medicine|2016|62
The In Vitro and In Vivo Antitumor Effects of Clotrimazole on Oral Squamous Cell Carcinoma
|PLoS ONE|2014|26
The oncogenic potential of PRR11 gene in Tongue Squamous Cell Carcinoma cells
|Journal of Cancer|2019|13